Literature DB >> 8406007

DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site.

T Czerny1, G Schaffner, M Busslinger.   

Abstract

Previous DNA-binding studies indicated that an intact paired domain is required for interaction of the transcription factor BSAP (Pax-5) with DNA. We have now identified a subset of BSAP recognition sequences that also bind to a truncated BSAP peptide lacking 36 carboxy-terminal amino acids of the paired domain. Sequence comparison of this class of BSAP-binding sites made it possible to unequivocally align all known BSAP-binding sites and to deduce a consensus sequence consisting of two distinct half sites. We propose here a model for the paired domain--DNA interaction in which the paired domain is composed of two subdomains that bind to the two half-sites in adjacent major grooves on the same side of the DNA helix. The existence of these half sites and of the two paired domain subregions was directly demonstrated by methylation interference analysis and by in vitro mutagenesis of both the paired domain and its recognition sequence. Both half-sites contribute to the overall affinity of a given BSAP-binding site according to their match with the consensus sequence. However, none of the naturally occurring BSAP-binding sites completely conform to the consensus sequence. Instead, they contain compensatory base changes in their half-sites that explain the versatile and seemingly degenerate DNA sequence recognition of Pax proteins. Domain swap experiments between BSAP and Pax-1 demonstrated that the sequence specificity of the BSAP paired domain is determined by both its amino- and carboxy-terminal subdomains. Moreover, mutations affecting only one of the two subdomains restricted the sequence specificity of the paired domain. Such mutations have been shown previously to be the cause of mouse developmental mutants (undulated, Splotch, and Small eye) and human syndromes (Waardenburg's syndrome and aniridia) and may thus differentially affect the regulation of target genes by the mutated Pax protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406007     DOI: 10.1101/gad.7.10.2048

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  121 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin.

Authors:  M S Lechner; I Levitan; G R Dressler
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

3.  Crystal structure of the human Pax6 paired domain-DNA complex reveals specific roles for the linker region and carboxy-terminal subdomain in DNA binding.

Authors:  H E Xu; M A Rould; W Xu; J A Epstein; R L Maas; C O Pabo
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

4.  Nephric lineage specification by Pax2 and Pax8.

Authors:  Maxime Bouchard; Abdallah Souabni; Markus Mandler; Annette Neubüser; Meinrad Busslinger
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

5.  WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8.

Authors:  Roberto Nitsch; Tina Di Palma; Anna Mascia; Mariastella Zannini
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

6.  The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.

Authors:  Roger Revilla-I-Domingo; Ivan Bilic; Bojan Vilagos; Hiromi Tagoh; Anja Ebert; Ido M Tamir; Leonie Smeenk; Johanna Trupke; Andreas Sommer; Markus Jaritz; Meinrad Busslinger
Journal:  EMBO J       Date:  2012-06-05       Impact factor: 11.598

7.  A binding site for homeodomain and Pax proteins is necessary for L1 cell adhesion molecule gene expression by Pax-6 and bone morphogenetic proteins.

Authors:  R Meech; P Kallunki; G M Edelman; F S Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  Comparative study of Pax2 expression in glial cells in the retina and optic nerve of birds and mammals.

Authors:  Jennifer Stanke; Holly E Moose; Heithem M El-Hodiri; Andy J Fischer
Journal:  J Comp Neurol       Date:  2010-06-15       Impact factor: 3.215

9.  A novel missense mutation in the paired domain of PAX9 causes non-syndromic oligodontia.

Authors:  Dolrudee Jumlongras; Jenn-Yih Lin; Anas Chapra; Christine E Seidman; Jonathan G Seidman; Richard L Maas; Bjorn R Olsen
Journal:  Hum Genet       Date:  2003-12-19       Impact factor: 4.132

10.  Highly conserved amino acids in Pax and Ets proteins are required for DNA binding and ternary complex assembly.

Authors:  D Fitzsimmons; R Lutz; W Wheat; H M Chamberlin; J Hagman
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.